Biomea Fusion, Inc.(BMEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

BMEA Biomea Fusion, Inc.

Not Yet Opened 07-16 16:00:00 EDT

1.26

-0.03

-2.33%

盘后1.27

+0.01+0.79%

19:54 EDT

High1.27	Low1.23	Vol552.77K
Open1.27	D1 Closing1.29	Amplitude3.10%
Mkt Cap91.10M	Tradable Cap84.43M	Total Shares72.30M
T/O688.30K	T/O Rate0.82%	Tradable Shares67.01M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"BMEA","market":"US","secType":"STK","nameCN":"Biomea Fusion, Inc.","latestPrice":1.26,"timestamp":1784232000000,"preClose":1.29,"halted":0,"volume":552774,"hourTrading":{"tag":"盘后","latestPrice":1.2699,"preClose":1.26,"latestTime":"19:54 EDT","volume":1333,"amount":1680.2233,"timestamp":1784246052870,"change":0.0099,"changeRate":0.007857,"amplitude":0.007857},"delay":0,"changeRate":-0.023255813953488393,"floatShares":67007373,"shares":72299440,"eps":-0.8918,"marketStatus":"Not Yet Opened","change":-0.03,"latestTime":"07-16 16:00:00 EDT","open":1.27,"high":1.27,"low":1.23,"amount":688304.234868,"amplitude":0.031008,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.8918,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1784275200000},"marketStatusCode":0,"adr":0,"listingDate":1618545600000,"exchange":"NASDAQ","adjPreClose":1.29,"preHourTrading":{"tag":"盘前","latestPrice":1.3,"preClose":1.29,"latestTime":"07:44 EDT","volume":29,"amount":37.4499968,"timestamp":1784202251275,"change":0.01,"changeRate":0.007752,"amplitude":0.007752},"postHourTrading":{"tag":"盘后","latestPrice":1.2699,"preClose":1.26,"latestTime":"19:54 EDT","volume":1333,"amount":1680.2233,"timestamp":1784246052870,"change":0.0099,"changeRate":0.007857,"amplitude":0.007857},"volumeRatio":0.612165,"impliedVol":1.0162,"impliedVolPercentile":0.536},"requestUrl":"/m/hq/s/BMEA/tweets","defaultTab":"tweets","newsList":[{"id":"2645831890","title":"Analysts Offer Insights on Healthcare Companies: Oric Pharmaceuticals (ORIC), Biomea Fusion (BMEA) and Senseonics Holdings (SENS)","url":"https://stock-news.laohu8.com/highlight/detail?id=2645831890","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2645831890?lang=en_us&edition=fundamental","pubTime":"2026-06-24 19:30","pubTimestamp":1782300628,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Oric Pharmaceuticals (ORIC), Biomea Fusion (BMEA) an...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-oric-pharmaceuticals-oric-biomea-fusion-bmea-and-senseonics-holdings-sens-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-oric-pharmaceuticals-oric-biomea-fusion-bmea-and-senseonics-holdings-sens-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4585","LU0128526141.USD","LABU","BK4581","HCSG","ORIC","BK4588","LU0029874061.USD","BK4082","XLV","BK4137","SENS","BMEA","XBI","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642826426","title":"Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA) and Novavax (NVAX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2642826426","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642826426?lang=en_us&edition=fundamental","pubTime":"2026-06-12 18:00","pubTimestamp":1781258436,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biomea Fusion (BMEA) and Novavax (NVAX) with bullish...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biomea-fusion-bmea-and-novavax-nvax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biomea-fusion-bmea-and-novavax-nvax-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","XLV","LU0029874061.USD","BK4137","LU0128526141.USD","BK4588","BK4539","BK4581","BK4585","NVAX","BK4139","HCSG","BK4547","BMEA","LABU","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642289856","title":"Biomea Fusion shareholders elect two directors at annual meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2642289856","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642289856?lang=en_us&edition=fundamental","pubTime":"2026-06-11 19:12","pubTimestamp":1781176343,"startTime":"0","endTime":"0","summary":"Biomea Fusion held its annual shareholder meeting on June 10, 2026.Shareholders selected two Class II directors, with terms running to the 2029 annual meeting.Shareholders ratified Deloitte & Touche LLP as independent registered public accounting firm for fiscal 2026.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biomea Fusion Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on June 11, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260611:nNDL489X4N:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BK4585","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641852224","title":"Biomea Labs: Buy Rating Reiterated as Icovamenib Data Strengthen Metabolic Disease Thesis; $4 Price Target Maintained","url":"https://stock-news.laohu8.com/highlight/detail?id=2641852224","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641852224?lang=en_us&edition=fundamental","pubTime":"2026-06-08 18:35","pubTimestamp":1780914928,"startTime":"0","endTime":"0","summary":"H.C. Wainwright analyst Joseph Pantginis maintained a Buy rating on Biomea Fusion today and set a price target of $4.00. Joseph Pantginis has given...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/biomea-labs-buy-rating-reiterated-as-icovamenib-data-strengthen-metabolic-disease-thesis-4-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/biomea-labs-buy-rating-reiterated-as-icovamenib-data-strengthen-metabolic-disease-thesis-4-price-target-maintained-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4585","BMEA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641239211","title":"Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“Ada”) 86TH Scientific Sessions and Announces Expansion of Ongoing Phase I Bmf-650 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2641239211","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641239211?lang=en_us&edition=fundamental","pubTime":"2026-06-06 07:32","pubTimestamp":1780702320,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nTUA6PVDT8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BMEA","BK4139","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641212397","title":"Biomea Fusion - Icovamenib Data Show Muscle Preservation and Fat Reduction in Obesity and Diabetes","url":"https://stock-news.laohu8.com/highlight/detail?id=2641212397","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641212397?lang=en_us&edition=fundamental","pubTime":"2026-06-06 07:32","pubTimestamp":1780702320,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nTUA6PVDT8:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BK4585","BK4539","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641123977","title":"Biomea Fusion - Icovamenib Improves Hba1c and C-Peptide in Type 1 Diabetes With No Immune Activation","url":"https://stock-news.laohu8.com/highlight/detail?id=2641123977","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641123977?lang=en_us&edition=fundamental","pubTime":"2026-06-06 07:32","pubTimestamp":1780702320,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nTUA6PVDT8:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BMEA","BK4139","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641123970","title":"Biomea Fusion: Expanded Phase I Bmf-650 Study to Evaluate a Rapid One-Step Titration, Enhanced Weight Loss Potential With Oral Glp-1 Receptor Agonist","url":"https://stock-news.laohu8.com/highlight/detail?id=2641123970","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641123970?lang=en_us&edition=fundamental","pubTime":"2026-06-06 07:32","pubTimestamp":1780702320,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260605:nTUA6PVDT8:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4139","BMEA","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641712392","title":"Biomea Fusion Presents New Clinical and Translational Data for Icovamenib at the American Diabetes Association (“ADA”) 86th Scientific Sessions and Announces Expansion of Ongoing Phase I BMF-650 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2641712392","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641712392?lang=en_us&edition=fundamental","pubTime":"2026-06-06 07:32","pubTimestamp":1780702320,"startTime":"0","endTime":"0","summary":"Translational data presented at ADA demonstrate icovamenib’s potential to promote muscle preservation and fat reduction, supporting its broader therapeutic utility in obesity and diabetes, including a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/05/3307662/0/en/Biomea-Fusion-Presents-New-Clinical-and-Translational-Data-for-Icovamenib-at-the-American-Diabetes-Association-ADA-86th-Scientific-Sessions-and-Announces-Expansion-of-Ongoing-Phase.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4107","BK4539","BK4585","BK4139","AFG","BMEA","BK4117"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641164049","title":"Biomea Fusion management to meet with Citizens","url":"https://stock-news.laohu8.com/highlight/detail?id=2641164049","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641164049?lang=en_us&edition=fundamental","pubTime":"2026-06-05 03:41","pubTimestamp":1780602079,"startTime":"0","endTime":"0","summary":"Citizens Happy Hour with Management.in New Orleans on June 6 hosted by Citizens. Published first on TheFly – the ultimate source for real-time, mar...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/biomea-fusion-management-to-meet-with-citizens-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/biomea-fusion-management-to-meet-with-citizens-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4539","BK4585","BK4139","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640183489","title":"Analysts Offer Insights on Healthcare Companies: Biomea Fusion (BMEA) and IDEAYA Biosciences (IDYA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640183489","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640183489?lang=en_us&edition=fundamental","pubTime":"2026-06-03 23:50","pubTimestamp":1780501821,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Biomea Fusion (BMEA) and IDEAYA Biosciences (IDYA) w...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biomea-fusion-bmea-and-ideaya-biosciences-idya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-biomea-fusion-bmea-and-ideaya-biosciences-idya-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBI","BK4539","IDYA","LABU","BK4139","BK4588","BMEA","XLV","BK4137","BK4585","HCSG","LU0029874061.USD","BK4581","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640016619","title":"Biomea Fusion, University of Leicester to study icovamenib plus semaglutide in obesity trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2640016619","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640016619?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:01","pubTimestamp":1780488106,"startTime":"0","endTime":"0","summary":"Biomea Fusion launched a University of Leicester collaboration to test menin inhibitor icovamenib with semaglutide in an obesity clinical study arm.The randomized, double-blind trial will compare the combination against semaglutide alone in overweight or obese adults without type 2 diabetes.The study will assess whether adding icovamenib can improve weight-loss outcomes while supporting physical function and body composition.Enrollment is set to start in Q3, with the primary assessment scheduled for Week 24.Late-breaking preclinical findings were scheduled for presentation at the ADA Scientific Sessions on June 7, 2026.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nNDL35YS20:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2W23.USD","BK4539","IE00BKPKM429.USD","IE00BN0W2V16.EUR","SG9999014005.SGD","IE00BGHQF748.EUR","BK4588","LU2210149790.SGD","IE00B64PRP62.GBP","BK4139","IE00B3QW5Z07.USD","BK4585","SG9999014039.USD","BK4112","NDAQ","LU2095319765.USD","SG9999014013.SGD","LU0314104364.USD","LU2210150020.SGD","BMEA","SG9999014021.USD","IE00BN0W2T93.GBP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640901163","title":"Biomea Fusion - Study to Evaluate Icovamenib With Semaglutide for Enhanced Weight Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2640901163","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640901163?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:00","pubTimestamp":1780488003,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA7BXPL1:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4585","BK4539","BK4139","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640015539","title":"Biomea Fusion Announces Research Collaboration With University of Leicester to Evaluate Icovamenib in Combination With Semaglutide in Obesity","url":"https://stock-news.laohu8.com/highlight/detail?id=2640015539","media":"THOMSON REUTERS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640015539?lang=en_us&edition=fundamental","pubTime":"2026-06-03 20:00","pubTimestamp":1780488003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260603:nTUA7BXPL1:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","BMEA","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635840667","title":"Oppenheimer Keeps Their Buy Rating on Biomea Fusion (BMEA)","url":"https://stock-news.laohu8.com/highlight/detail?id=2635840667","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635840667?lang=en_us&edition=fundamental","pubTime":"2026-05-13 20:16","pubTimestamp":1778674618,"startTime":"0","endTime":"0","summary":"In a report released today, Matthew Biegler from Oppenheimer reiterated a Buy rating on Biomea Fusion, with a price target of $9.00. According to T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/oppenheimer-keeps-their-buy-rating-on-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/oppenheimer-keeps-their-buy-rating-on-biomea-fusion-bmea-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BMEA","OPY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635405812","title":"Biomea Fusion to Participate at Upcoming Investor Conferences","url":"https://stock-news.laohu8.com/highlight/detail?id=2635405812","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635405812?lang=en_us&edition=fundamental","pubTime":"2026-05-13 04:05","pubTimestamp":1778616300,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif., May  12, 2026  (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion”) (Nasdaq: BMEA), a clinical-stage diabetes and obesity company, today announced that management ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/05/12/3293383/0/en/Biomea-Fusion-to-Participate-at-Upcoming-Investor-Conferences.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","BK4585","BK4139","BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634253730","title":"Biomea Fusion Inc reports results for the quarter ended March 31 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2634253730","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634253730?lang=en_us&edition=fundamental","pubTime":"2026-05-12 05:44","pubTimestamp":1778535842,"startTime":"0","endTime":"0","summary":"Biomea Fusion Inc reports results for the quarter ended March 31 - Earnings SummaryBiomea Fusion Inc BMEA.OQ reported a quarterly adjusted loss of 17 cents per share for the quarter ended March 31, hi","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL8N41O2PT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","BMEA","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634253315","title":"Biomea Fusion Q1 EPS $(0.17) Beats $(0.24) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2634253315","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634253315?lang=en_us&edition=fundamental","pubTime":"2026-05-12 05:16","pubTimestamp":1778534185,"startTime":"0","endTime":"0","summary":"Biomea Fusion (NASDAQ:BMEA) reported quarterly losses of $(0.17) per share which beat the analyst consensus estimate of $(0.24) by 29.17 percent. This is a 78.75 percent increase over losses of $(0.80) per share from the","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/05/52472216/biomea-fusion-q1-eps-0-17-beats-0-24-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Biomea Fusion Q1 EPS $(0.17) Beats $(0.24) Estimate","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BMEA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634258781","title":"Biomea Fusion Q1 net loss narrows as expenses fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2634258781","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634258781?lang=en_us&edition=fundamental","pubTime":"2026-05-12 05:05","pubTimestamp":1778533534,"startTime":"0","endTime":"0","summary":"Biomea Fusion Q1 net loss narrows as expenses fallOverviewUS diabetes and obesity drug developer's Q1 net loss narrowed yr/yrOperating expenses for Q1 fell sharply, driven by lower clinical activity a","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nL1N41O13Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BMEA","BK4539","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634525852","title":"Biomea Fusion Q1 FY26 net loss narrows to $12.4 million; cash falls to $45.1 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2634525852","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2634525852?lang=en_us&edition=fundamental","pubTime":"2026-05-12 04:55","pubTimestamp":1778532912,"startTime":"0","endTime":"0","summary":"Biomea Fusion posted a net loss attributable to common stockholders of USD 12.4 million, narrowing from USD 29.3 million a year earlier; loss per share improved to USD 0.17 from USD 0.80.R&D expense fell to USD 9.1 million from USD 22.9 million, due to lower external costs and personnel-related spending tied to reduced headcount.G&A expense dropped to USD 3.7 million from USD 6.8 million, on lower personnel-related and corporate costs.Cash, cash equivalents and restricted cash declined to USD 45.1 million as of March 31, 2026; cash runway projected into first quarter of 2027.Chronic toxicology studies completed for icovamenib to support dosing beyond 12 weeks; Phase II T2D trials COVALENT-211 and -212 began dosing with 26-week topline data expected in Q4 2026, while Phase I BMF-650 obesity study remained on track for initial 28-day weight data in Q2 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260511:nNDL9PK7Cx:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","BK4588","BK4112","LU2210150020.SGD","IE00BKPKM429.USD","BK4585","LU0314104364.USD","IE00B3QW5Z07.USD","SG9999014039.USD","BK4539","IE00BGHQF748.EUR","SG9999014005.SGD","IE00BN0W2T93.GBP","BK4139","SG9999014013.SGD","NDAQ","LU2095319765.USD","SG9999014021.USD","BMEA","LU2210149790.SGD","IE00BN0W2W23.USD","IE00BN0W2V16.EUR"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.biomeafusion.com","stockEarnings":[{"period":"1week","weight":-0.0382},{"period":"1month","weight":0.0862},{"period":"3month","weight":-0.4299},{"period":"6month","weight":-0.1064},{"period":"1year","weight":-0.3403},{"period":"ytd","weight":0.0161}],"compareEarnings":[{"period":"1week","weight":-0.0013},{"period":"1month","weight":0.0005},{"period":"3month","weight":0.0571},{"period":"6month","weight":0.0854},{"period":"1year","weight":0.2027},{"period":"ytd","weight":0.1009}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Biomea Fusion, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin for treating patients with liquid and solid tumors and type 2 diabetes. Biomea Fusion, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.06322},{"month":2,"riseRate":0.4,"avgChangeRate":0.025302},{"month":3,"riseRate":0.4,"avgChangeRate":0.163799},{"month":4,"riseRate":0,"avgChangeRate":-0.156763},{"month":5,"riseRate":0.666667,"avgChangeRate":0.113922},{"month":6,"riseRate":0.5,"avgChangeRate":0.078877},{"month":7,"riseRate":0.333333,"avgChangeRate":-0.039902},{"month":8,"riseRate":0.8,"avgChangeRate":0.078281},{"month":9,"riseRate":0.4,"avgChangeRate":-0.012411},{"month":10,"riseRate":0.2,"avgChangeRate":-0.126858},{"month":11,"riseRate":0.4,"avgChangeRate":-0.034764},{"month":12,"riseRate":0.4,"avgChangeRate":-0.114655}],"exchange":"NASDAQ","name":"Biomea Fusion, Inc.","nameEN":"Biomea Fusion, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.46.0","shortVersion":"4.46.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Biomea Fusion, Inc.(BMEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Biomea Fusion, Inc.(BMEA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Biomea Fusion, Inc.,BMEA,Biomea Fusion, Inc.股票,Biomea Fusion, Inc.股票老虎,Biomea Fusion, Inc.股票老虎国际,Biomea Fusion, Inc.行情,Biomea Fusion, Inc.股票行情,Biomea Fusion, Inc.股价,Biomea Fusion, Inc.股市,Biomea Fusion, Inc.股票价格,Biomea Fusion, Inc.股票交易,Biomea Fusion, Inc.股票购买,Biomea Fusion, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Biomea Fusion, Inc.(BMEA),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Biomea Fusion, Inc.(BMEA) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction